- 全部删除
- 您的购物车当前为空
Henagliflozin (SHR3824) is an effective, oral, and selective SGLT2 inhibitor that effectively inhibits human SGLT2 in vitro, but has very weak inhibitory effects on human SGLT1.
Henagliflozin (SHR3824) is an effective, oral, and selective SGLT2 inhibitor that effectively inhibits human SGLT2 in vitro, but has very weak inhibitory effects on human SGLT1.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 74,600 | 10-14周 | |
50 mg | 待询 | 10-14周 | |
100 mg | 待询 | 10-14周 |
产品描述 | Henagliflozin (SHR3824) is an effective, oral, and selective SGLT2 inhibitor that effectively inhibits human SGLT2 in vitro, but has very weak inhibitory effects on human SGLT1. |
别名 | SHR-3824, SHR3824, SHR 3824 |
分子量 | 454.87 |
分子式 | C22H24ClFO7 |
CAS No. | 1623804-44-3 |
密度 | 1.494 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容